Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 23079079)

1.

Effect of natural and chimeric haemagglutinin genes on influenza A virus replication in baby hamster kidney cells.

van Wielink R, Harmsen MM, Martens DE, de Leeuw OS, Peeters BP, Wijffels RH, Moormann RJ.

J Biotechnol. 2012 Dec 31;162(2-3):197-201. doi: 10.1016/j.jbiotec.2012.10.005. Epub 2012 Oct 16.

PMID:
23079079
2.
3.

Improvement of H5N1 influenza vaccine viruses: influence of internal gene segments of avian and human origin on production and hemagglutinin content.

Abt M, de Jonge J, Laue M, Wolff T.

Vaccine. 2011 Jul 18;29(32):5153-62. doi: 10.1016/j.vaccine.2011.05.036. Epub 2011 May 30.

PMID:
21624413
4.

Molecular signature of high yield (growth) influenza a virus reassortants prepared as candidate vaccine seeds.

Ramanunninair M, Le J, Onodera S, Fulvini AA, Pokorny BA, Silverman J, Devis R, Arroyo JM, He Y, Boyne A, Bera J, Halpin R, Hine E, Spiro DJ, Bucher D.

PLoS One. 2013 Jun 11;8(6):e65955. doi: 10.1371/journal.pone.0065955. Print 2013.

5.

Antibodies induced by the HA2 glycopolypeptide of influenza virus haemagglutinin improve recovery from influenza A virus infection.

Gocník M, Fislová T, Mucha V, Sládková T, Russ G, Kostolansky F, Varecková E.

J Gen Virol. 2008 Apr;89(Pt 4):958-67. doi: 10.1099/vir.0.83524-0.

6.

Reassortant H1N1 influenza virus vaccines protect pigs against pandemic H1N1 influenza virus and H1N2 swine influenza virus challenge.

Yang H, Chen Y, Shi J, Guo J, Xin X, Zhang J, Wang D, Shu Y, Qiao C, Chen H.

Vet Microbiol. 2011 Sep 28;152(3-4):229-34. doi: 10.1016/j.vetmic.2011.04.032. Epub 2011 Apr 30.

PMID:
21596495
7.

The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines.

O'Donnell CD, Vogel L, Matsuoka Y, Jin H, Subbarao K.

J Virol. 2014 Nov;88(21):12374-84. doi: 10.1128/JVI.01107-14. Epub 2014 Aug 13.

8.

Immune effects against influenza A virus and a novel DNA vaccine with co-expression of haemagglutinin- and neuraminidase-encoding genes.

Zhang W, Li W, Li Y, Li H, Wang B, Wang F, Zhu Y, Jiang Z, Zhong L, Li M.

J Med Microbiol. 2009 Jul;58(Pt 7):845-54. doi: 10.1099/jmm.0.006825-0. Epub 2009 Jun 4.

9.

1918 Influenza virus hemagglutinin (HA) and the viral RNA polymerase complex enhance viral pathogenicity, but only HA induces aberrant host responses in mice.

Watanabe T, Tisoncik-Go J, Tchitchek N, Watanabe S, Benecke AG, Katze MG, Kawaoka Y.

J Virol. 2013 May;87(9):5239-54. doi: 10.1128/JVI.02753-12. Epub 2013 Feb 28.

10.

Generation of influenza A viruses with chimeric (type A/B) hemagglutinins.

Horimoto T, Takada A, Iwatsuki-Horimoto K, Hatta M, Goto H, Kawaoka Y.

J Virol. 2003 Jul;77(14):8031-8.

11.

A live bivalent influenza vaccine based on a H9N2 virus strain.

Wu R, Guan Y, Yang Z, Chen J, Wang H, Chen Q, Sui Z, Fang F, Chen Z.

Vaccine. 2010 Jan 8;28(3):673-80. doi: 10.1016/j.vaccine.2009.10.102. Epub 2009 Nov 3.

PMID:
19892041
12.

Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.

Shi H, Liu XF, Zhang X, Chen S, Sun L, Lu J.

Vaccine. 2007 Oct 16;25(42):7379-84. Epub 2007 Aug 24.

PMID:
17870216
13.

Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.

Park KS, Seo YB, Lee JY, Im SJ, Seo SH, Song MS, Choi YK, Sung YC.

Vaccine. 2011 Jul 26;29(33):5481-7. doi: 10.1016/j.vaccine.2011.05.062. Epub 2011 Jun 12.

PMID:
21664216
14.

Productivity, apoptosis, and infection dynamics of influenza A/PR/8 strains and A/PR/8-based reassortants.

Isken B, Genzel Y, Reichl U.

Vaccine. 2012 Jul 27;30(35):5253-61. doi: 10.1016/j.vaccine.2012.05.065. Epub 2012 Jun 12.

PMID:
22698452
15.

Generation and evaluation of reassortant influenza vaccines made by reverse genetics for H9N2 avian influenza in Korea.

Song JM, Lee YJ, Jeong OM, Kang HM, Kim HR, Kwon JH, Kim JH, Seong BL, Kim YJ.

Vet Microbiol. 2008 Aug 25;130(3-4):268-76. doi: 10.1016/j.vetmic.2008.02.005. Epub 2008 Feb 16.

PMID:
18374520
16.

Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.

Du N, Li W, Li Y, Liu S, Sui Y, Qu Z, Wang Y, Du Y, Xu B.

Vaccine. 2008 Jun 2;26(23):2912-8. doi: 10.1016/j.vaccine.2008.03.048. Epub 2008 Apr 11.

PMID:
18448208
17.
18.

[Immune protective effectiveness of seasonal influenza spilt vaccine against homologous and heterogonous subtypes of influenza virus in mice].

Huang BY, Wang XP, Wang WL, Hu W, Gao Q, Tan WJ, Ruan L.

Bing Du Xue Bao. 2011 May;27(3):265-73. Chinese.

PMID:
21774253
19.

Generation of recombinant pandemic H1N1 influenza virus with the HA cleavable by bromelain and identification of the residues influencing HA bromelain cleavage.

Wang W, Suguitan AL Jr, Zengel J, Chen Z, Jin H.

Vaccine. 2012 Jan 20;30(5):872-8. doi: 10.1016/j.vaccine.2011.11.101. Epub 2011 Dec 13.

PMID:
22172510
20.

The N terminus of PA polymerase of swine-origin influenza virus H1N1 determines its compatibility with PB2 and PB1 subunits through a strain-specific amino acid serine 186.

Wanitchang A, Jengarn J, Jongkaewwattana A.

Virus Res. 2011 Jan;155(1):325-33. doi: 10.1016/j.virusres.2010.10.032. Epub 2010 Nov 5.

PMID:
21056603
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk